• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Devex CheckUp

    Devex CheckUp: Is ivermectin the new hydroxychloroquine?

    In today's CheckUp: Doctors debate whether COVID-19 patients should receive ivermectin, Nestlé’s WHO Foundation donation, and politics influence vaccines in Venezuela.

    By Amruta Byatnal, Jenny Lei Ravelo // 15 April 2021
    Sign up to Devex CheckUp, a new global health newsletter.

    This is a preview of our latest newsletter, Devex CheckUp. Sign up to receive exclusive global health news and insider insights, in your inbox every Thursday.

    This time last year, hydroxychloroquine was making headlines. There were high-profile claims about its possible use as a treatment for COVID-19 — ones that didn’t stand up to the scrutiny of clinical trials. And so this week, we’re asking: Is ivermectin just history repeating itself?

    • With more attention turning to ivermectin, some large-scale randomized trials may include the drug to gather more data. As doctors debate whether COVID-19 patients should receive it, Jenny asks if there is any merit to the hype.

    • The Philippines has seen growing interest in the drug despite warnings from health authorities not to use ivermectin. The Department of Health said it couldn’t guarantee the safety or quality of the drug, which is currently not approved for human intake in the country.

    • However, some Indian states have included ivermectin in their COVID-19 treatment protocols — despite WHO’s recent recommendation to only use the drug in clinical trials.

    • Vaccine hesitancy and the lack of doses in many countries may explain why the controversial drug can be attractive. With 37 nations and territories yet to start vaccination drives, Sara Jerving reports on why the rollout remains slow in a number of countries that have vaccines.

    Exclusive: WHO Foundation gets a reality check

    A recent donation from multinational food and beverage company Nestlé to the COVID-19 Solidarity Response Fund, now managed by the WHO Foundation, has sparked concern among some global health community members. But there is no quid pro quo in any contributions, Anil Soni, the foundation’s CEO, tells Jenny in this exclusive story.

    It appears that the @thewhof sold the World Health Organization halo to Nestle for the low, low price of $2.15 million. https://t.co/eRP0oe8ASa

    — Lucy M. Sullivan (@lucymsullivan) April 7, 2021
    Via Twitter.

    There were concerns that such a donation could be a vehicle to influence WHO, which is the main recipient of donations to the fund.

    Exclusive: WHO Foundation pushes back against criticism over Nestlé donation

    Interactive: What is the state of the world population?

    Note: The adolescent birth rate per 1,000 girls.

    UNFPA’s new “State of World Population 2021” report paints a concerning picture of women's self-determination: 45% of women globally are not empowered to make choices around their own health care, contraception, and consent to sex. Plus, 27% do not have access to comprehensive sexual education. Lisa Cornish delves into the data.

    Spotlight on: Venezuela

    • Venezuela has one of the lowest vaccination rates in the world: As of April 9, less than 0.4% of the population had received at least one shot of the COVID-19 vaccine, compared to 4.3% in neighboring Colombia.

    • Following months of negotiation, the country has finally paid COVAX $64 million — half of the total amount for the 11 million doses expected to inoculate 20% of the population.

    • The country has also received 500,000 doses of China’s Sinopharm and 250,000 of Russia’s Sputnik V vaccines.

    Read: Augusta Saraiva reports on Venezuela’s messy, political vaccine rollout.

    Global health job of the week

    Senior Technical Advisor, Covid-19 Vaccine Introduction
    Management Sciences for Health
    Amman, Jordan

    See more jobs

    Did you know

    According to a new report by the Global Child Nutrition Foundation, 1 in 4 children get meals at school in countries that include a line item of these programs in their national budgets — compared to less than 2 in 10 kids in countries without.

    Read: More kids fed when school meals are national budget item, report finds

    Quotable

    “We need to have the political will to [boost COVID-19 vaccine manufacturing in Africa] ... and that can only be done if we come together as a continent. Otherwise, that’s just a waste of time.”

    — Mo Ibrahim, founder, Mo Ibrahim Foundation’

    Read more on Africa’s push to increase COVID-19 vaccine manufacturing.

    What we’re reading

    Rollouts of the Johnson & Johnson vaccine have been paused in the U.S., EU, and South Africa after 6 reported cases of rare blood clots in the U.S. [BBC]

    WHO calls for a halt in sales of wild animals in food markets to prevent the emergence of new diseases. [Al Jazeera]

    Despite evidence that COVID-19 is rarely fatal in young children, Brazil has recorded more than 500 infant deaths from the disease. [BBC]

    • Global Health
    • Private Sector
    • Venezuela
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the authors

    • Amruta Byatnal

      Amruta Byatnalamrutabyatnal

      Amruta Byatnal is a Senior Editor at Devex where she edits coverage on global development, humanitarian crises and international aid. She writes Devex CheckUp, a weekly newsletter on the latest developments in global health. Previously, she worked for News Deeply in the United States, and The Hindu in India. She is a graduate of Cornell University where she studied international development. She is currently based in New Delhi.
    • Jenny Lei Ravelo

      Jenny Lei Ravelo@JennyLeiRavelo

      Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.

    Search for articles

    Related Stories

    Devex CheckUpDevex CheckUp: Why isn’t there enough cholera vaccine to go around?

    Devex CheckUp: Why isn’t there enough cholera vaccine to go around?

    Devex CheckUpDevex CheckUp: Is it curtains for UNAIDS?

    Devex CheckUp: Is it curtains for UNAIDS?

    Devex CheckUpDevex CheckUp: Where would WHO be without US money?

    Devex CheckUp: Where would WHO be without US money?

    Devex CheckUpDevex CheckUp: USAID cuts threaten global health research

    Devex CheckUp: USAID cuts threaten global health research

    Most Read

    • 1
      How low-emissions livestock are transforming dairy farming in Africa
    • 2
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 3
      Opinion: India’s bold leadership in turning the tide for TB
    • 4
      How AI-powered citizen science can be a catalyst for the SDGs
    • 5
      Strengthening health systems by measuring what really matters
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement